





1st Session, 37th Parliament,
49-50-51 Elizabeth II, 2001-2002 










House of Commons of Canada










BILL C-460









An Act to amend the Patent Act







R.S., c. P-4


Her Majesty, by and with the advice and 
consent of the Senate and House of Commons 
of Canada, enacts as follows:









1. Section 55.2 of the Patent Act is 
amended by adding the following after 
subsection (4):







Exception


(4.1) Subsection (4) does not apply in 
respect of medicines.  










2. The Act is amended by adding the 
following after section 55.2:







Exception


55.3 It is not an infringement of a patent for 
any person to make, construct, use or sell a 
patented invention that is intended or capable 
of being used for medicine or the preparation 
or production of medicine solely for uses 
reasonably related to the export of an article, 
machine, manufacture or composition of 
matter, the making, constructing, using or 
selling of which would otherwise infringe that 
patent.







Definitions


55.4 (1) The definitions in this subsection 
apply in this section.







``court''
« tribunal »


``court'' means any court of competent 
jurisdiction.







``first person''
« première 
personne »


``first person'' has the same meaning as in 
section 2 of the Regulations, as they read 
immediately before the coming into force 
of this section.







``Regulations'
'
« Règlement »


``Regulations'' means the Patented Medicines 
(Notice of Compliance) Regulations.







``second 
person''
« seconde 
personne »


``second person'' has the same meaning as in 
section 2 of the Regulations, as they read 
immediately before the coming into force 
of this section.







``submission''
« présentation
 »


``submission'' means a submission referred to 
in section C.08.004 of the Food and Drug 
Regulations.







Revocation of 
orders


(2) Any order under subsection 6(1) of the 
Regulations is revoked.







Dismissal of 
applications


(3) Any application under subsection 6(1) 
of the Regulations is dismissed without costs.







Notice of 
compliance


(4) Where, as a result of the operation of 
section 7 of the Regulations or an order under 
subsection 6(1) of the Regulations, the 
Minister of Health was prevented from or 
delayed in issuing a notice of compliance in 
respect of a drug that is the subject of a second 
person's submission, that Minister shall 
immediately issue










(a) a certificate specifying the date on 
which a notice of compliance would have 
been issued had it not been for the operation 
of that section or that order; and









(b) the notice of compliance, if it has not 
been issued already.






Payment


(5) The first person shall pay to the second 
person










(a) costs on a solicitor and client basis in 
respect of the period beginning on the date 
specified by the Minister of Health under 
paragraph (4)(a) and ending on the date on 
which a notice of compliance was issued to 
the second person; and









(b) damages in an amount to be determined 
by a court under subsection (6).






Assessment of 
damages


(6) In assessing the amount of damages, the 
court shall assume that










(a) the number of prescriptions that would 
have been filled using the second person's 
drug would have been equal to fifty per cent 
of the number of prescriptions that were 
filled using the first person's drug; and









(b) the price at which the second person's 
drug would have been sold would have been 
equal to seventy-five per cent of the price at 
which the first person's drug was sold.  






Repeal 
SOR/93-133


3. The Patented Medicines (Notice of 
Compliance) Regulations are repealed.








